KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Equity Ratio (2017 - 2025)

Historic Equity Ratio for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to 0.71.

  • Twist Bioscience's Equity Ratio fell 459.18% to 0.71 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.71, marking a year-over-year decrease of 459.18%. This contributed to the annual value of 0.74 for FY2025, which is 423.59% down from last year.
  • Latest data reveals that Twist Bioscience reported Equity Ratio of 0.71 as of Q4 2025, which was down 459.18% from 0.74 recorded in Q3 2025.
  • Twist Bioscience's 5-year Equity Ratio high stood at 0.91 for Q1 2021, and its period low was 0.71 during Q4 2025.
  • Moreover, its 5-year median value for Equity Ratio was 0.8 (2023), whereas its average is 0.8.
  • Data for Twist Bioscience's Equity Ratio shows a peak YoY increase of 1116.28% (in 2021) and a maximum YoY decrease of 1265.74% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Twist Bioscience's Equity Ratio stood at 0.8 in 2021, then rose by 2.97% to 0.82 in 2022, then decreased by 1.83% to 0.81 in 2023, then decreased by 6.95% to 0.75 in 2024, then fell by 4.59% to 0.71 in 2025.
  • Its Equity Ratio was 0.71 in Q4 2025, compared to 0.74 in Q3 2025 and 0.74 in Q2 2025.